SAGE logo

Sage Therapeutics (SAGE) Net Income

Annual Net Income

-$541.49 M
-$8.71 M-1.63%

December 31, 2023


Summary


Performance

SAGE Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSAGEprofitabilitymetrics:

Quarterly Net Income

-$93.55 M
+$9.30 M+9.04%

September 30, 2024


Summary


Performance

SAGE Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSAGEprofitabilitymetrics:

TTM Net Income

-$337.59 M
+$108.08 M+24.25%

September 30, 2024


Summary


Performance

SAGE TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSAGEprofitabilitymetrics:

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

SAGE Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.6%+9.0%+24.3%
3 y3 years-189.3%+28.1%-152.6%
5 y5 years-45.2%+48.0%+50.4%

SAGE Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.3%at low-186.0%+53.6%at high+48.5%
5 y5-year-189.3%+20.4%-109.6%+53.6%-150.7%+50.4%
alltimeall time-189.3%+20.4%-109.6%+53.6%-150.7%+50.4%

Sage Therapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$93.55 M(-9.0%)
-$337.59 M(-24.3%)
Jun 2024
-
-$102.85 M(-5.2%)
-$445.67 M(-11.4%)
Mar 2024
-
-$108.48 M(+231.7%)
-$503.14 M(-7.1%)
Dec 2023
-$541.49 M(+1.6%)
-$32.71 M(-83.8%)
-$541.49 M(-17.4%)
Sep 2023
-
-$201.63 M(+25.8%)
-$655.93 M(+10.9%)
Jun 2023
-
-$160.32 M(+9.2%)
-$591.62 M(+6.1%)
Mar 2023
-
-$146.83 M(-0.2%)
-$557.56 M(+4.6%)
Dec 2022
-$532.78 M(+16.4%)
-$147.15 M(+7.2%)
-$532.78 M(+4.4%)
Sep 2022
-
-$137.32 M(+8.8%)
-$510.35 M(+1.4%)
Jun 2022
-
-$126.26 M(+3.4%)
-$503.20 M(+3.9%)
Mar 2022
-
-$122.06 M(-2.1%)
-$484.18 M(+5.7%)
Dec 2021
-$457.89 M(-175.6%)
-$124.71 M(-4.2%)
-$457.89 M(-171.4%)
Sep 2021
-
-$130.17 M(+21.4%)
$641.72 M(-3.7%)
Jun 2021
-
-$107.25 M(+12.0%)
$666.15 M(+4.6%)
Mar 2021
-
-$95.76 M(-109.8%)
$637.05 M(+5.1%)
Dec 2020
$606.07 M(-189.1%)
$974.89 M(-1022.0%)
$606.07 M(-212.8%)
Sep 2020
-
-$105.73 M(-22.5%)
-$537.48 M(-12.1%)
Jun 2020
-
-$136.35 M(+7.6%)
-$611.70 M(-5.0%)
Mar 2020
-
-$126.74 M(-24.9%)
-$643.57 M(-5.4%)
Dec 2019
-$680.24 M(+82.4%)
-$168.65 M(-6.3%)
-$680.24 M(+1.5%)
Sep 2019
-
-$179.96 M(+7.0%)
-$669.97 M(+9.3%)
Jun 2019
-
-$168.22 M(+2.9%)
-$612.93 M(+32.8%)
Mar 2019
-
-$163.41 M(+3.2%)
-$461.69 M(+23.8%)
Dec 2018
-$372.88 M
-$158.39 M(+28.9%)
-$372.88 M(+31.3%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$122.92 M(+624.0%)
-$283.92 M(+21.0%)
Jun 2018
-
-$16.98 M(-77.2%)
-$234.72 M(-18.5%)
Mar 2018
-
-$74.60 M(+7.5%)
-$287.94 M(+6.6%)
Dec 2017
-$270.12 M(+69.9%)
-$69.42 M(-5.8%)
-$270.12 M(+5.3%)
Sep 2017
-
-$73.72 M(+5.0%)
-$256.60 M(+16.3%)
Jun 2017
-
-$70.20 M(+23.6%)
-$220.68 M(+19.1%)
Mar 2017
-
-$56.78 M(+1.6%)
-$185.22 M(+16.5%)
Dec 2016
-$158.99 M(+68.2%)
-$55.90 M(+47.9%)
-$158.99 M(+20.8%)
Sep 2016
-
-$37.80 M(+8.8%)
-$131.65 M(+11.7%)
Jun 2016
-
-$34.75 M(+13.8%)
-$117.89 M(+9.0%)
Mar 2016
-
-$30.54 M(+6.9%)
-$108.17 M(+14.5%)
Dec 2015
-$94.50 M(+179.5%)
-$28.56 M(+18.8%)
-$94.50 M(+20.7%)
Sep 2015
-
-$24.04 M(-4.0%)
-$78.29 M(+22.9%)
Jun 2015
-
-$25.03 M(+48.3%)
-$63.73 M(+42.0%)
Mar 2015
-
-$16.87 M(+36.5%)
-$44.89 M(+32.8%)
Dec 2014
-$33.81 M(+85.0%)
-$12.36 M(+30.6%)
-$33.81 M(+24.5%)
Sep 2014
-
-$9.47 M(+52.9%)
-$27.17 M(+22.3%)
Jun 2014
-
-$6.19 M(+6.9%)
-$22.22 M(+7.4%)
Mar 2014
-
-$5.79 M(+1.3%)
-$20.68 M(+13.1%)
Dec 2013
-$18.28 M(+89.8%)
-$5.72 M(+26.5%)
-$18.28 M(+45.5%)
Sep 2013
-
-$4.52 M(-2.9%)
-$12.56 M(+56.2%)
Jun 2013
-
-$4.66 M(+37.4%)
-$8.04 M(+137.4%)
Mar 2013
-
-$3.39 M
-$3.39 M
Dec 2012
-$9.63 M
-
-

FAQ

  • What is Sage Therapeutics annual net profit?
  • What is the all time high annual net income for Sage Therapeutics?
  • What is Sage Therapeutics annual net income year-on-year change?
  • What is Sage Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Sage Therapeutics?
  • What is Sage Therapeutics quarterly net income year-on-year change?
  • What is Sage Therapeutics TTM net profit?
  • What is the all time high TTM net income for Sage Therapeutics?
  • What is Sage Therapeutics TTM net income year-on-year change?

What is Sage Therapeutics annual net profit?

The current annual net income of SAGE is -$541.49 M

What is the all time high annual net income for Sage Therapeutics?

Sage Therapeutics all-time high annual net profit is $606.07 M

What is Sage Therapeutics annual net income year-on-year change?

Over the past year, SAGE annual net profit has changed by -$8.71 M (-1.63%)

What is Sage Therapeutics quarterly net profit?

The current quarterly net income of SAGE is -$93.55 M

What is the all time high quarterly net income for Sage Therapeutics?

Sage Therapeutics all-time high quarterly net profit is $974.89 M

What is Sage Therapeutics quarterly net income year-on-year change?

Over the past year, SAGE quarterly net profit has changed by +$9.30 M (+9.04%)

What is Sage Therapeutics TTM net profit?

The current TTM net income of SAGE is -$337.59 M

What is the all time high TTM net income for Sage Therapeutics?

Sage Therapeutics all-time high TTM net profit is $666.15 M

What is Sage Therapeutics TTM net income year-on-year change?

Over the past year, SAGE TTM net profit has changed by +$108.08 M (+24.25%)